Changes

'''Novartis''' is a pharmaceutical multinational from Switzerland that specializes in biotechnological drug production and distribution, as well as a vast array of consumer healthcare products, including the manufacturing of vaccines, the development of over-the-counter pharmaceuticals not requiring prescrptions, as well as animal healthcare products and the production of contact lenses and various lense care products. It is the world's 5th largest vaccine producer, and its presence is noted in over 140 countries worldwide through 100.000 or so associates<ref>[http://www.novartis.com/about-novartis/people/index.shtml "About Novartis: Facts"]</ref>. The company formerly owned the Gerber Products Company, a major infant and baby products producer, but sold it to Nestlé on September, 2007.<ref>Novartis, [http://www.novartis.com/newsroom/media-releases/en/2007/1150584.shtml "Novartis completes divestment program with transfer of Gerber baby foods business"], Media Release, September 03, 2007.</ref> In addition to internal research and development activities, Novartis is also involved in publicly funded collaborative research projects, with other industrial and academic partners. One example in the area of non-clinical safety assessment is the InnoMed PredTox. The company is also expanding its activities in joint research projects within the framework of the Innovative Medicines Initiative of EFPIA and the European Commission.